Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

L-asparaginase encapsulated in erythrocytes

EU orphan designation number: EU/3/09/633   
Active ingredient: L-asparaginase encapsulated in erythrocytes
Indication: Treatment of pancreatic cancer
Sponsor: ERYtech Pharma S.A.
60 avenue Rockefeller, Bâtiment Adenine, 69008 Lyon, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/05/2009 Orphan designation EMEA/OD/100/08 (2009)4052 of 15/05/2009